Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

Last month, the ISPOR annual meeting in Montreal was brimming with opportunities to explore the latest developments and ...

In today’s fast-paced experience economy, pharma companies can no longer rely on static displays and outdated engagement ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...

Moderna’s respiratory syncytial virus (RSV) vaccine mRESVIA has been approved by the US Food and Drug Administration (FDA) ...

AstraZeneca (AZ) has announced promising results from a late-stage study of its C5 complement inhibitor Ultomiris ...